DSM-Firmenich
Kaiseraugst, Switzerland
EFFECTIVENESS ASSESSMENT: HIGH COMMERCIAL IMPACT — the leading private-sector innovator. Bovaer (3-NOP) is now approved in 70+ countries including FDA approval in the US. Demonstrates 30% methane reduction in dairy cows, 45% in beef cattle. The first commercially viable enteric methane solution at scale. Key limitation: cost and delivery logistics for smallholder farmers (hundreds of millions globally) remain unsolved — Bovaer works for industrial-scale operations but not yet for the farmers who collectively produce most agricultural methane.
Links
Connections
Enteric Methane Innovation Labparticipates in
5/5